UK - 3i's Nolan to assume UK buyout leadership role
3i has announced that its pan-European buyout business has given responsibility for its UK buyout operations to Ian Nolan.
In his previous role Nolan held overall responsibility for several of 3i's German buyout deals, most notably that of Betapharm, the generic pharmaceutical company which was recently sold to Indian Dr. Reddy's Laboratories Ltd in the €480m transaction. His investment track record also includes the buyout of Thomson Directories, development funding for Telecity, the successful refinancing and subsequent IPO of Morse and acquisition funding for Pets at Home.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds








